ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $373,860 | -19.8% | 124,620 | 0.0% | 0.00% | – |
Q2 2023 | $466,079 | +55.5% | 124,620 | +39.2% | 0.00% | – |
Q1 2023 | $299,825 | -26.9% | 89,500 | +4.9% | 0.00% | – |
Q4 2022 | $410,293 | -10.0% | 85,300 | +6.5% | 0.00% | – |
Q3 2022 | $456,000 | -19.9% | 80,100 | 0.0% | 0.00% | – |
Q2 2022 | $569,000 | -1.6% | 80,100 | 0.0% | 0.00% | – |
Q1 2022 | $578,000 | -19.0% | 80,100 | +0.3% | 0.00% | – |
Q4 2021 | $714,000 | -78.9% | 79,900 | -17.0% | 0.00% | -100.0% |
Q3 2021 | $3,376,000 | +75.0% | 96,288 | +7.2% | 0.00% | 0.0% |
Q2 2021 | $1,929,000 | +66.1% | 89,800 | +377.6% | 0.00% | 0.0% |
Q1 2021 | $1,161,000 | +118.6% | 18,802 | +48.0% | 0.00% | – |
Q4 2020 | $531,000 | – | 12,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
CM Management, LLC | 100,000 | $894,000 | 0.68% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
Parkwood LLC | 71,932 | $643,000 | 0.11% |